Carestream prepares to unveil RIS/PACS pricingOther headlines:IDC revenues plummetMindray revenues skyrocketAmicas slips in 1Q
Carestream will focus on a new licensing structure for its latest generation of RIS/PACS at the Society for Imaging Informatics in Medicine meeting June 4 to 7. The new licensing approach offers tiered pricing tied to imaging volume. This approach allows for enterprise-wide use of the suite's advanced features for users of all sizes, according to the company. Key features of the Carestream PACS are a new PowerViewer workstation, new RIS for centralized enterprise-wide scheduling, and new "SuperPACS" architecture that creates a single user interface for disparate PACS.
A slowing economy cut gross revenues 58.8% at Imaging Dynamics Company for the quarter ended March 31 compared with the year-earlier period, but the digital radiography firm trimmed its losses by 40%. The company credited a reduced cash burn and better capital managing for the improved bottom line. Net loss for the quarter was $1.5 million compared with $2.5 million in the same quarter 2008. Net revenues were $2.6 million versus $6.4 million in 1Q 08.
Net revenues boomed 53.5% for Mindray Medical International in the first quarter over the year-earlier period, but profits edged barely higher. Net income grew 1.2% to $25.3 million for the Chinese medical device maker, whose portfolio includes ultrasound scanners. Quarterly revenues rose to $134.2 million from $87.4 million. Ultrasound revenues increased 32.9% to $35.7 million, contributing 26.6% to the total net revenues in the first quarter 2009.
Revenues dropped 12% in the first quarter at Amicas, ballooning the PACS/IT company's operating losses 33% (to $1.6 million) compared with the year-earlier period. Total revenues in the quarter ended March 31 were $11.3 million compared with $12.8 million in 1Q 08. The $1.6 million operating loss included $549,000 in expenses related to the acquisition and integration of Emageon.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.